27 February 2018 At: ACC/HO 011/61 Re: Management Discussion and Analysis for the year ended 31 December 2017 To: President The Stock Exchange of Thailand In the first half of 2017 the Thai economy

(Translation) NEP-AC 001/2562 28 February 2019 Subject : Management Discussion and Analysis for year ended 31 December 2018 To : The President The Stock Exchange of Thailand Operating Result NEP

Microsoft Word - NWR 030_E_Year18 (Translation) No.FN-NWR 030/2562 28 February 2019 Subject : Submission of Financial Statements for the Years ended 31 December 2018 To : President The Stock Exchange

. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public

Microsoft Word - NWR 93-62_E_Q1 (Translation) No.FN-NWR 093/62 14 May 2019 Subject : Submission of Financial Statements for the first quarter ended March 31,2019 To : President The Stock Exchange of

(Translation) NEP-AC 002/2562 15 May 2019 Subject: Management Discussion and Analysis for 1st Quarter ended 31 March 2019 To : The President The Stock Exchange of Thailand Operating Result NEP Realty

period of 2018 To : The President of the Stock Exchange of Thailand The Company would like to provide details of changes in Profit and Loss as shown in the six-month period ending 30 June 2019 reviewed

Microsoft Word - NWR 75-61_E_Q1 (Translation) No.FN-NWR 075/61 15 May 2018 Subject : Submission of Financial Statements for the first quarter ended March 31,2018 To : President The Stock Exchange of

[COMPANY NAME] Ref.:EFORL020/2018 May 15, 2018 Subject: Management Discussion and Analysis for the first quarter ended 31 March 2018 To President The Stock Exchange of Thailand 1. Overview financial

/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited